4.3 Article

Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells

Journal

IMMUNE NETWORK
Volume 22, Issue 6, Pages -

Publisher

KOREA ASSOC IMMUNOLOGISTS
DOI: 10.4110/in.2022.22.e50

Keywords

Clonal anergy; Syndecan-1; Follicular B cell; Transitional B cell; B cell receptor repertoire

Categories

Funding

  1. Korea Medical Device Development Fund from the Korean Government (the Ministry of Science and ICT) [KMDF_PR_20200901_0004, NTIS 9991006677]
  2. Korea Medical Device Development Fund from the Korean Government (Ministry of Trade, Industry and Energy) [KMDF_PR_20200901_0004, NTIS 9991006677]
  3. Korea Medical Device Development Fund from the Korean Government (Ministry of Health and Welfare) [KMDF_PR_20200901_0004, NTIS 9991006677]
  4. Korea Medical Device Development Fund from the Korean Government (Ministry of Food and Drug Safety) [KMDF_PR_20200901_0004, NTIS 9991006677]
  5. Korea Basic Science Institute (National Research Facilities and Equipment Center) grant of the Ministry of Education (Korea) [2020R1A6C101A191]
  6. National Research Foundation of Korea
  7. BK21 FOUR Program (Graduate School Innovation) of Sungkyunkwan University
  8. National Research Foundation of Korea [2020R1A6C101A191] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

This study identifies naturally occurring anergic B cells in normal mice characterized by low-level expression of CD138, downregulation of IgM, reduced Ca2+ and CD69 responses upon BCR engagement, and distinct BCR repertoire.
B cells are not entirely deleted, but some remain as immunocompetent or anergic B cells. Although the persistence of autoreactive B cells as anergic cells has been shown in transgenic mouse models with the expression of B cell receptor (BCR) reactive to engineered self-antigen, the characterization of naturally occurring anergic B cells is important to identify them and understand their contribution to immune regulation or autoimmune diseases. We report here that a low-level expression of CD138 in the splenic B cells marks naturally arising anergic B cells, not plasma cells. The CD138int B cells consisted of IgM(low)IgD(high) follicular (FO) B cells and transitional 3 B cells in homeostatic conditions. The CD138(int) FO B cells showed an anergic gene expression profile shared with that of monoclonal anergic B cells expressing engineered BCRs and the gene expression profile was different from those of plasma cells, age-associated B cells, or germinal center B cells. The anergic state of the CD138(int) FO B cells was confirmed by attenuated Ca2+ response and failure to upregulate CD69 upon BCR engagement with anti-IgM, anti-IgD, anti-Ig., or antiIgG. The BCR repertoire of the CD138(int) FO B cells was distinct from that of the CD138- FO B cells and included some class-switched B cells with low-level somatic mutations. These findings demonstrate the presence of polyclonal anergic B cells in the normal mice that are characterized by low-level expression of CD138, IgM downregulation, reduced Ca2+ and CD69 responses upon BCR engagement, and distinct BCR repertoire.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available